BP11091 PCL, poly(ε-caprolactone), Carboxyl-Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa

PCL, poly(ε-caprolactone), Carboxyl-Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa Description

Poly(ε-caprolactone) is a biodegradable, semi-crystalline polyester synthesised via ring-opening polymerisation. The carboxyl termination enhances its compatibility in functional modifications. Its inherent viscosity indicates polymer chain length, directly influencing mechanical properties and degradation rates. The specified molecular weight range provides predictable processability, making the material suitable for advanced biomedical and controlled release applications where consistency is critical.

PCL, poly(ε-caprolactone), Carboxyl-Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa Applications

1.         Biomedical Applications
   - Used as a scaffold material in tissue engineering to achieve controlled biodegradation by leveraging its predictable degradation rate.
   - Applied in drug delivery systems to secure sustained release by utilising its defined polymer chain characteristics.

2.         Industrial Applications
   - Employed as a carrier in composite matrices to enhance mechanical integrity by utilising its processability and biodegradability.

PCL, poly(ε-caprolactone), Carboxyl-Terminated, IV: 1.0–1.5 dl/g, Mw: 112–198 kDa Packing

The polymer powder is packaged in moisture-resistant, sealed containers with anti-static lining to minimise contamination. Each package is clearly labelled with storage instructions. It is recommended to store the product in a cool, dry, and temperature-controlled environment. Custom packaging solutions, including vacuum sealing and tailored container sizes, are available to meet specific shipping and application requirements.

Additional Information

PCL (polycaprolactone) is a biodegradable polyester extensively studied in the field of biocompatible materials. Its controlled degradation and ease of processing make it a valuable material for biomedical applications such as tissue scaffolding and drug delivery systems. Understanding the relationship between molecular weight and intrinsic viscosity is critical for tailoring its performance.

The carboxyl termination enhances the polymer's aqueous dispersibility and provides active sites for further chemical modification, thereby improving its compatibility with hydrophilic matrices and facilitating ionic interaction or covalent grafting within composite systems. This expands the material's applicability in advanced manufacturing and functional biomaterial design. Ongoing research continues to refine processing techniques to optimise performance and reliability across diverse applications.

Regulatory Note: This material is intended for industrial and consumer applications. It is the user's responsibility to ensure compliance with all applicable safety and regulatory requirements for its intended use.